Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05388214

Exercise and Cognitive Rehab in Older Cancer Survivors

The objective of the study is to evaluate the feasibility of a combined mobile health exercise and cognitive rehabilitation intervention and its effect on cognition in a single-arm pilot study that recruits cancer survivors.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Cancer Behavior Motor Activity Neoplasms

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Rochester

Rochester, New York, 14642, United States

Location status: Recruiting

Location contact

Kah Poh Loh

CONTACT

[email protected]

(585) 276-4353

Kah Poh Loh

PRINCIPAL_INVESTIGATOR

About this study

Cancer survivors (i.e., those who completed cancer-directed treatment) often experience long-term treatment-related effects, such as cancer-related cognitive decline (CRCD). Exercise and cognitive rehabilitation (rehab) interventions have been shown to improve CRCD symptoms in both cancer and non-cancer populations. Among older adults without cancer, studies have also demonstrated that multicomponent interventions combining exercise and cognitive rehab are more effective in improving cognitive dysfunction than either intervention alone. However, exercise adherence and self-efficacy are lower in older adults compared to younger adults, and combined interventions may be too demanding for older cancer survivors. Therefore, innovative ways are needed to integrate an exercise program within the context of a cognitive rehab program to increase exercise adherence and self-efficacy, and ultimately improve CRCD symptoms through a streamlined multicomponent intervention.

In this study, the investigators propose to refine a multicomponent Exercise and COgnitive rehab intervention (E-Co) and assess its feasibility in older cancer survivors.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥60 years at the time of consent
  • Have a diagnosis of any cancer
  • Have completed curative intent treatments
  • Patients on endocrine therapies are allowed to enroll
  • Patients with hematologic malignancies after autologous or allogeneic stem cell transplant are allowed to enroll as long as they have completed curative-intent treatment
  • Have concerns about memory or other thinking abilities following cancer treatment*
  • English speaking (because the interventions are available in English language only)
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-3
  • No medical contraindications for exercise per oncologist#
  • Able to walk 4 meters#
  • Able to provide informed consent#

(*) Confirmed by asking the patient (#) Confirmed through eligibility confirmation with the patient's oncologist or their designee

Exclusion criteria

  • Physical, psychological, or social impairments that would interfere with patient's ability to participate in the study or participate in the intervention, as determined by the PIs and oncology team.

Treatment and study plan

E-Co

Behavioral

The E-Co intervention will integrate active components of a mobile health exercise intervention (GO-EXCAP) into a cognitive rehabilitation intervention (MAAT-G).

Primary outcomes

  1. Feasibility of the intervention

    Time frame: Post-intervention at week 12

    Feasibility is defined based on adherence to the intervention components: 1) At least 70% of patients provide exercise data on 50% on the intervention days; and 2) At least 70% of patients attend at least 8/10 of the MAAT-G workshops.

Secondary outcomes

  1. Self-reported cognition

    Time frame: Baseline and post-intervention at week 12

    Functional Assessment of Cancer Therapy-Cognition (FACT-Cog): The FACT-Cog is a validated patient reported outcome measure created to assess cognitive challenges identified by patients with cancer. It has 37 items and has four domains in Perceived Cognitive Impairments (PCI), Impact of PCI on Quality of Life, Comments from Others, and Perceived Cognitive Abilities. Score ranges from 0-148, higher score indicates better self-reported cognition.

  2. Cambridge Neuropsychological Test Automated Battery (CANTAB)

    Time frame: Baseline and post-intervention at week 12

    The CANTAB Delayed Matching to Sample assesses both simultaneous visual matching ability and short-term visual recognition memory, for non-verbalisable patterns. The subject is shown a complex visual pattern, followed by four similar patterns after a brief delay. The subject must select the pattern which exactly matches the sample. Better speed of response and higher number of correct patterns indicate better health outcomes. (Patients only)

  3. Controlled Oral Word Association (COWA)

    Time frame: Baseline and post-intervention at week 12

    The Controlled Oral Word Association (COWA) tool is a measure of verbal fluency evaluating expressive language and executive function. Subjects are asked to freely generate as many words as they can that start with one of the prompted letters ("C", "F", and "L") in the span of one minute. Greater numbers of words indicate better health outcomes.

  4. Hopkins Verbal Learning Test-Revised (HVLT-R)

    Time frame: Baseline and post-intervention at week 12

    The Hopkins Verbal Learning Test-Revised (HVLT-R) tool is a test of verbal learning and memory. Researchers read a list of 12 words to subjects and ask them to report as many of the words as they can recall. The reporting period is timed. Higher numbers of correctly remembered words, along with lower reporting times, are indicative of better health outcomes.

Study contacts

Contact information is provided by the study sponsor or research team.

Becky Gravenstede

CONTACT

[email protected]

585-727-4728

Kah Poh Loh

CONTACT

[email protected]

585-276-4353

Sponsors and collaborators

Lead sponsor

University of Rochester

Other

Registry information

Official study title

An Exercise and COgnitive Rehabilitation Intervention for Older Cancer Survivors (The E-Co Study)

Acronym: E-Co

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
May 24, 2022
Registry last updated
Apr 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.